Xeris Biopharma Holdings, Inc.
Develops ready-to-use injectable drugs for chronic, metabolic, and rare diseases.
XERS | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1375 WEST FULTON STREET, SUITE 1300, 60607 CHICAGO
- Website:
- https://www.xerispharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Xeris Biopharma Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative, ready-to-use injectable and infusible drug formulations. The company utilizes its proprietary technology platforms to create therapies that are easier for patients and caregivers to use, aiming to reduce treatment burdens and overall healthcare costs. Xeris concentrates on addressing unmet medical needs in various therapeutic areas, with a particular focus on chronic endocrine, metabolic, and other rare diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Xeris Biopharma Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xeris Biopharma Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xeris Biopharma Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
